written by reader SFTBY

By Anonymous Questions, November 23, 2014

On March 19, 2014 Travis Johnson wrote an article about SFTBY as a way to get in on the BABA IPO.

I would like his opinion as to why SFTBY, a 32% stakeholder in BABA has not moved up in view of the current BABA price of $110; A 70% increase since the IPO was issued.

Thank You

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.

guest

12345

This site uses Akismet to reduce spam. Learn how your comment data is processed.

6 Comments
Inline Feedbacks
View all comments
Altaf
Guest
January 4, 2015 10:33 am

The answer IMO is simple, there is no financial good data showing its performance and dividend to attract traders. Only $0.06 cash div. in Sept last declaration with Gross Yield 0.57% is the factor behind no increase. However watch in Feb 2015.

THOMAS LINHARES
Guest
THOMAS LINHARES
January 25, 2015 6:42 pm
Reply to  Altaf

I AM A SUB SCRIBER TO YOUR PERIODICAL AND AM VERY INTERESTED IN YOUR STANSBERRY VENTURE. HOW DO I INVEST IN THIS COMPANY. THE ARTICLE IS ABOUT A DRUG THAT WILL REDUCE/ELININATE PAIN.

TOMLINHARES

Add a Topic
4482
Travis Johnson, Stock Gumshoe
January 26, 2015 10:02 am

We don’t publish Stansberry Venture, but we did write about one of their ads here: http://www.stockgumshoe.com/reviews/stansberry-venture/whats-stansberry-venture-1/ — it wasn’t a pain medicine, but perhaps there have been more recent ads that I’ve not yet seen.

Add a Topic
4482
👍 17329
Travis Johnson, Stock Gumshoe
January 4, 2015 10:46 am

Softbank has had other problems — their core business at home is in Yen, which makes performance looks worse in dollars, and their investment in US telecom (they own Sprint) is expensive and they were unable to get the green light from regulators to take over T-Mobile and become a real competitor to Verizon and AT&T.

I said I’d prefer Softbank to Yahoo as an Alibaba play largely because Softbank owned more of BABA and wasn’t planning to sell, which is still true, but their other businesses are disappointing.

Add a Topic
1142
Add a Topic
4097
👍 17329
RattleR
Irregular
RattleR
January 26, 2015 11:29 am

Travis — Watched a documentary Sunday about ALS and Ismed — a biopharmaceutical out of NJ that had supposed great success with a treatment for ALS, but, alas the good ole’ FDA would only grant VERY few patients access to the treatment (guess protocol is a better term) Wondering if you or Dr. KSS have any thoughts on the company or it’s research–Thanks–All The Best!

Add a Topic
3022
Add a Topic
3932
👍 3
RattleR
Irregular
RattleR
January 26, 2015 11:30 am

Company is Insmed–please excuse the typo

👍 3

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

More Info